Regular blood tests can identify prostate cancer patients who are resistant to treatment – News-Medical.Net

Regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with docetaxel, according to research presented at the NCRI Festival.
The findings could enable…

Click here to view the original article.